期刊文献+

肿瘤标志物联合检测与宫颈癌早期诊断的相关性 被引量:12

下载PDF
导出
摘要 目前发现早期子宫颈癌最为有效的方法是子宫颈涂片检查。血清肿瘤标志物检测在宫颈癌的辅助诊断和病情监测方面已经成为临床上不可或缺的一种诊疗手段。为提高宫颈癌早期诊断率,本文联合检测血清中肿瘤标志物SCCA、CA125、CA19-9、CEA的含量,探讨其与宫颈癌早期诊断的相关性。
作者 刘馨 白艳香
出处 《中国老年学杂志》 CAS CSCD 北大核心 2013年第13期3155-3156,共2页 Chinese Journal of Gerontology
基金 辽宁省科技厅科技攻关项目(No.2011225015)
  • 相关文献

参考文献5

  • 1连丽娟,林巧稚.妇科肿瘤学[M].第3版.北京:人民卫生出版社,2008:288.
  • 2Yasumatsu B, Nakashima T, Azuma K,et al. SCCA expression in T lym- phocytes peripheral to cancer ceils is associated with the elevation of- serum SCC antigen in squamous cell carcinoma of the tongue [ J]. Cancer Lett,2001 ,167(2) :205-13.
  • 3Diez M, Cerdan FJ, Ortega MD, et al. Evaluation of serum CA125 as a tumor marker in nonsmall cell lung cancer[ J]. Cancer,1991 ,67( 1 ) :150-4.
  • 4姚嘉斐,高娜,黄立.子宫颈癌与肿瘤标志物[J].中国实用妇科与产科杂志,2003,19(3):130-133. 被引量:3
  • 5甘玉杰,熊小英,符丽华,谭玲玲.血清SccAg、CA125、CA19-9在宫颈癌及癌前病变中的表达及意义[J].中国妇幼保健,2012,27(10):1543-1546. 被引量:12

二级参考文献19

  • 1雷君,张彤,谌宏鸣.5种肿瘤标志物在宫颈癌检测中的信息提示和临床应用[J].新疆医科大学学报,2005,28(2):165-167. 被引量:14
  • 2[11]Takeshima N,Hirai Y,Katase K,et al.The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer. Gynecol Oncol, 1998,68(3):263
  • 3[12]Takeda M, Sakuragi N, Okamoto K,et al. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix. Acta Obstet Gynecol Scand, 2002, 81(5): 451
  • 4[14]Scambia G,Benedetti P,Foti E,et al.Mutiple tumor marker assays in advanced cervical cancer:relationship to chemotherapy response and clinical outcome. Eur J Cancer,1996,32(2):259
  • 5[15]Kim BG,Kim JH,Park SY,et al. Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy. Gynecol Oncol,1996,63(1):105
  • 6[16]Numa F. Squamous cell carcinoma antigen as a useful marker in neoadjuvant chemotherapy for locally advanced cancer of the uterine cervix. Tumor Biol, 2000 21(suppll):47
  • 7[17]Roszak, Bratos K,Gomy A,et al.Evaluation of SCC antigen in patients with advanced cervix cancer treated with radiation. Ginekol Pol,1996,67(9):457
  • 8[18]Micke O, Prott FJ, Schafer U,et al. The impact of squamous cell carcinoma (SCC) antigen in the follow-up after radiotherapy in patients with cervical cancer. Anticancer Res, 2000 , 20:5113
  • 9[19]Tabata T, Takeshima N, Tanaka N,et al. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma. Tumour Biol, 2000, 21(6):375
  • 10[1]Meyer T, Rustin GJ. Role of tumour markers in monitoring epithelial ovarian cancer.Br J Cancer, 2000, 82(9):1535

共引文献13

同被引文献71

引证文献12

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部